For the ongoing COVID-19 pandemic, the absence of sex-disaggregated data remains an information black hole : Is the biological risk of infection the same for women and men? Are more women getting tested than men? Are women observing social distancing protocols more than men? Research has shown that sex-disaggregated data from testing to fatalities improves the targeting of risk communication, sentinel surveillance, and treatments. ![]() The collection of sex-disaggregated data informs real-time understanding of the biology of an infectious disease as well as the social and economic factors that contribute to risk of exposure. However, as reported by Global Health 5050, “no single country is reporting sex disaggregated data across the key indicators that show who is getting tested, sick and dying from COVID-19.” This means that we do not know “the sex of roughly 4 in 10 cases and 3 in 10 deaths globally”. The 2019 Novel Coronavirus Strategic Preparedness and Response Plan, published by the WHO on 4 February 2020, emphasised: “Disaggregated data on age, sex, pregnancy status and outcome (as appropriate) should be reported”. The collection of sex-disaggregated health data has been a strong recommendation of the Inter-Agency and Expert Group on Sustainable Development Goal Indicators (IAEG-SDGs) and the World Health Organization (WHO) National Action Plan for Health Security. Tracking sex and gender in real time of COVID-19 The exclusion of this knowledge in real time affects the design of effective prevention and recovery. Gender stereotypes and gendered differences lead to different patterns of exposure and treatment. ConclusionĪt the outset of health emergencies in China, gender research needs to be prioritised during the first stage of an outbreak to assist with evaluation of the most effective public health measures, identifying access to healthcare and social welfare barriers amongst priority communities. There was minimal consideration of the economic, social and security factors, including gender stereotypes and expectations, that affected different populations’ experiences of infection, treatment, and lockdown during the period of review. There was an absence of research on the gendered impact of COVID-19 amongst populations. Near the end of the six-month literature review period, a small number of research items emerged on women healthcare workers, women’s mental health, and pregnant women’s access to care. In China, only a small portion of the COVID-19-related research focused on gender experiences and differences. We used a COVID-19 Gender Matrix informed by the JPHIEGO gender analysis toolkit to examine and illuminate research into the gendered impacts of COVID-19 within China. We conducted an exhaustive search of published Chinese and English language research papers on COVID-19 in mainland China. ![]() ![]() In this scoping review, we examine the first 6 months (January–June 2020) of peer-reviewed publications ( n = 451) on sex and gender experiences related to COVID-19 in China. In China, the country with the longest history of fighting the COVID-19 infection, what research was available on the gender-differential impacts of COVID-19 in the first 6 months of the COVID-19 pandemic? Methods The collection of sex-disaggregated data should also better inform our understanding of the gendered impacts that contribute to risk of exposure to COVID-19. The collection of sex-disaggregated data on COVID-19 testing, infection rates, hospital admissions, and deaths, when available, has informed our understanding of the biology of the infectious disease. During the course of the COVID-19 pandemic, states were called upon by the World Health Organization to introduce and prioritise the collection of sex-disaggregated data.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |